153 related articles for article (PubMed ID: 34805946)
1. Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma.
Zheng L; Li H; Huang J; Shin J; Luo S; Guo C; Zhao Y; Li F
J Interv Med; 2021 Feb; 4(1):39-45. PubMed ID: 34805946
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
[TBL] [Abstract][Full Text] [Related]
3. The value of serum midkine level in diagnosis of hepatocellular carcinoma.
Shaheen KY; Abdel-Mageed AI; Safwat E; AlBreedy AM
Int J Hepatol; 2015; 2015():146389. PubMed ID: 25737783
[TBL] [Abstract][Full Text] [Related]
4. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
Christou C; Stylianou A; Gkretsi V
Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
[TBL] [Abstract][Full Text] [Related]
5. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis.
Lu Q; Li J; Cao H; Lv C; Wang X; Cao S
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
8. Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma.
Hodeib H; ELshora O; Selim A; Sabry NM; El-Ashry HM
Electron Physician; 2017 Jan; 9(1):3492-3498. PubMed ID: 28243398
[TBL] [Abstract][Full Text] [Related]
9. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
10. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
11. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
12. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
13. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
Ma WJ; Wang HY; Teng LS
World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Li L; Chen J; Xu W; Ding X; Wang X; Liang J
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e336-e340. PubMed ID: 29071776
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
17. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
19. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
[TBL] [Abstract][Full Text] [Related]
20. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
